tiprankstipranks
Trending News
More News >
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Income Statement

Compare
559 Followers

Relay Therapeutics Income Statement

Last quarter (Q4 2025), Relay Therapeutics's total revenue was $7.00M, an increase of Infinity% from the same quarter last year. In Q4, Relay Therapeutics's net income was $-54.89M. See Relay Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 15.36M$ 10.01M$ 25.55M$ 1.38M$ 3.03M
Gross Profit
$ 11.80M$ 10.01M$ 25.55M$ 1.38M$ 3.03M
Operating Expenses
$ 314.54M$ 382.48M$ 398.55M$ 300.66M$ 367.73M
Depreciation and Amortization
$ 3.56M$ 5.46M$ 5.27M$ 4.13M$ 3.92M
EBITDA
$ -272.92M$ -380.21M$ -374.15M$ -306.82M$ -223.08M
Operating Income
$ -302.74M$ -372.47M$ -373.00M$ -299.27M$ -364.70M
Other Income/Expenses
$ 26.26M$ 34.76M$ 31.03M$ 8.77M$ 826.00K
Pretax Income
$ -276.48M$ -337.71M$ -341.97M$ -290.51M$ -363.87M
Net Income
$ -276.48M$ -337.71M$ -341.97M$ -290.51M$ -363.87M
Per Share Metrics
Basic EPS
$ -1.61$ -2.36$ -2.79$ -2.59$ -3.82
Diluted EPS
$ -1.61$ -2.36$ -2.79$ -2.59$ -3.82
Weighted Average Shares Outstanding
171.59M 142.87M 122.58M 112.23M 95.14M
Weighted Average Shares Outstanding (Diluted)
171.59M 142.87M 122.58M 112.23M 95.14M
Currency in USD

Relay Therapeutics Earnings and Revenue History